Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

HCV Diagnosis in Prison by Testing & Telemedicine

J Viral Hepat; ePub 2018 Oct 13; Morey, et al

A universal offer of blood borne virus (BBV) testing to inmates coupled with linkage into specialist care via telemedicine clinics (TC) can substantially increase rates of testing, diagnosis, and treatment of hepatitis C virus (HCV) in a studied prison population. A universal offer of BBV testing was initially implemented in March 2016. Researchers found:

  • From March 2016 to February 2017, 2,831 of 4,280 (66%) new receptions were offered BBV testing.
  • Of these, 1,495 (53% of offered) accepted BBV testing, of whom 95 (6.4%) were HCV antibody positive, with 47 (49.5%) HCV RNA positive, suggesting a prevalence of active infection in the tested population of 3.1%.
  • Between August 2015 and October 2017, 80 individuals were seen in the TC and 57 (71%) commenced antiviral therapy.
  • Of those with known outcome (n=29), 100% received sustained virological response.

Citation:

Morey S, Hamoodi A, Jones D, et al. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine. [Published online ahead of print October 13, 2018]. J Viral Hepat. doi:10.1111/jvh.13017.